March 12, 2020

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control

In by Susan Lawrence

Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control Publication Current Diabetes Reports Date November 2019 Authors Jagdeesh Ullal,1 Joseph Aloi2 ABSTRACT Purpose of Review: The goal of this review is to summarize information about insulin dosing software and calculators used as computerized decision support systems or electronic glucose management systems (eGMS). These are used for hospitalized, insulin-treated patients with diabetes. …

December 10, 2019

Reducing Critical Hypoglycemia Through Quality Improvement Initiatives and Implementation of an eGlycemic Management System

In by Heather DelCarpini

Reducing Critical Hypoglycemia Through Quality Improvement Initiatives and Implementation of an eGlycemic Management System Presentation IHI National For​um on Quality Improvement in Health Care Date December 2019 Authors Debra Dudley,1 Gam Narapanya,2 Michael Yurso,2 Mary Gaines,3 Jennifer Crowe,3 AIM Reduce critical hypoglycemia (blood glucose <40 mg/dL) among hospitalized patients within two years. BACKGROUND On average, one of every three hospitalized …

Technology-Enabled Glycemic Management Leads to Reductions in Variation and Increased Use of Basal Bolus Regimens for Subcutaneous Insulin Therapy

In by Heather DelCarpini

Technology-Enabled Glycemic Management Leads to Reductions in Variation and Increased Use of Basal Bolus Regimens for Subcutaneous Insulin Therapy Presentation IHI National For​um on Quality Improvement in Health Care Date December 2019 Authors Susan M. De Abate,1 H. Courtenay Harrison, Jr.,1 Jordan Messler,2 AIM Decrease clinical practice variation for glycemic management and increase the number of insulin-requiring patients treated with …

February 15, 2018

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander

In by Heather DelCarpini

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2018 Authors Bruce Bode, John Clarke, Andrew Rhinehart, Robby Booth BACKGROUND Effective basal bolus insulin therapy requires dose titration to identify the right doses for each individual patient. Self-monitoring of blood glucose …

January 1, 2018

Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year

In by Heather DelCarpini

Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year Publication Journal of Diabetes Science and Technology Date January 2018 Authors Bruce Bode,1 John G. Clarke,1 Joseph Johnson1 ABSTRACT Purpose: The purpose was to improve the quality of care of at-risk patients through the addition of connected BG meters and CDSS to improve workflow …

Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System

In by Heather DelCarpini

Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System Publication Journal of Diabetes Science and Technology Date January 2018 Authors Rosalina Newsom,1 Christopher Patty,1 Emma Camarena,1 Regina Sawyer,1 Raymie McFarland,2 Thomas Gray,1 Melanie Mabrey2 ABSTRACT Objective: Hyperglycemia is common in the inpatient setting and providers frequently rely on …

November 3, 2017

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing

In by Heather DelCarpini

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing Presentation Annual Diabetes Technology Meeting Date November 2017 Authors Jagdeesh Ullal, Raymie McFarland, H. Courtenay Harrison, Amy Bedingfield, Jessica Sheehan, Susan DeAbate, Christine Dignan, Rebecca Cwik, Genevieve Thompson, Paul Chidester INTRODUCTION This prospective quality improvement project evaluated the effectiveness an electronic glycemic management system (eGMS®) utilizing Glucommander™ and admission …

September 12, 2017

Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year

In by Heather DelCarpini

Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year Presentation European Association for the Study of Diabetes Annual Meeting Date September 2017 Authors Andrew Rhinehart, John Clarke, Robby Booth INTRODUCTION Multiple issues continue to plague diabetes management: High insulin attrition rates1 Ineffective doses of insulin and insufficient dose adjustments2 Insufficient adult endocrinologists …

June 11, 2017

Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System

In by Heather DelCarpini

Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System Presentation American Diabetes Association Scientific Sessions Date June 2017 Authors Rosalina Newsom, Christopher Patty, Emma Camarena, Thomas Gray, Regina Sawyer, Brian Brown, Raymie McFarland BACKGROUND Hyperglycemia affects up to 40% of hospitalized patients and is associated with poor outcomes, …

May 19, 2017

Implementation of the eGlycemic Management System A Medical Center Case Study

In by Heather DelCarpini

Implementation of the eGlycemic Management System: A Medical Center Case Study Presentation International Hospital Diabetes Meeting Date May 2017 Authors Rosalina Newsom, Christopher Patty, Emma Camarena, Thomas Gray, Regina Sawyer, Brian Brown, Raymie McFarland BACKGROUND Hyperglycemia affects up to 40% of hospitalized patients and is associated with poor outcomes, including increased mortality, length of stay and surgical site infections. The …

May 4, 2017

“AUTO Study” AUtomatic Titration tO Target Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting

In by Heather DelCarpini

“AUTO Study” AUtomatic Titration tO Target: Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress Date May 2017 Authors Joseph Aloi,1 Jagdeesh Ullal,2,3 Paul Chidester,3 Raymie McFarland4 BACKGROUND Hyperglycemia affects 30-40% of hospitalized patients and can be linked to poor outcomes, including increased mortality, longer length of hospitalization, …

February 15, 2017

Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen

In by Heather DelCarpini

Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 Courtenay Harrison2 OBJECTIVE The importance of inpatient glycemic control on outcomes not only applies to patients managed with IV insulin in critical care areas but also patients on general surgical and …

Glucommander Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months

In by Heather DelCarpini

Glucommander Outpatient, A Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 John Clarke1 BACKGROUND Treatment of diabetes with multiple daily injections (MDI), using a regimen of long-acting basal and rapid-acting bolus …

November 10, 2016

Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative

In by Heather DelCarpini

Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative Presentation Annual Diabetes Technology Meeting Date November 2016 Authors April Mumpower,1 Suqin Hou,2 Tamera Parsons,1 Raymie McFarland2 OBJECTIVE The CMS Hospital Readmission Reduction (HRR) program was initiated in 2012 to encourage hospitals …

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG?

In by Heather DelCarpini

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG? Presentation Annual Diabetes Technology Meeting Date November 2016 Authors April Mumpower,1 Tamera Parsons1 OBJECTIVE The CMS Hospital Readmission Reduction (HRR) program added Coronary Artery Bypass Grafting (CABG) to their list of diagnoses that will be measured beginning in October 2016. Hospitals will be penalized for readmission rates …

August 23, 2016

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting

In by Heather DelCarpini

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting Publication Journal of Diabetes Science and Technology Date August 2016 Authors Joseph Aloi,1 Bruce Bode,2 Jagdeesh Ullal,3 Paul Chidester,4 Raymie McFarland,5 Amy Bedingfield,5 Melanie Mabrey,5 Robby Booth,5 April Mumpower,6 Amisha Wallia7 ABSTRACT Background: American Diabetes Association (ADA) guidelines recommend a basal bolus …

June 12, 2016

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points

In by Heather DelCarpini

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors John Clarke, Bruce Bode, Robby Booth, Harry Hebblewhite BACKGROUND Treatment of diabetes with multiple daily injections, using a regimen of basal and rapid-acting insulins is widely accepted as the standard of care. …

May 26, 2016

Improved Inpatient Hypoglycemia Rates With Electronic Glycemic Management System

In by Heather DelCarpini

Improved Inpatient Hypoglycemia Rates With Electronic Glycemic Management System Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress Date May 2016 Authors Joseph Aloi,1 Paul Chidester,2 Amy Henderson,3 Robby Booth,3 Raymie McFarland,3 April Mumford,4 Jagdeesh Ullal5 Background Hypoglycemia is a common adverse event for patients treated with insulin in the hospital setting, and is often considered the rate-limiting step …

October 22, 2015

eGlycemic Management System Provides Safe and Effective Glycemic Control for Stroke Patients Requiring Subcutaneous Insulin in the Hospital Setting

In by Heather DelCarpini

eGlycemic Management System Provides Safe and Effective Glycemic Control for Stroke Patients Requiring Subcutaneous Insulin in the Hospital Setting Presentation Annual Diabetes Technology Meeting Date October 2015 Authors Jagdeesh Ullal, Melanie Mabrey, Amy Henderson, Raymie McFarland, Robby Booth, Joseph Aloi Objective Admission hyperglycemia (>130 mg/dL) and persistent inpatient hyperglycemia (>48 hours) have been predictors of poor patient outcomes, including higher …

June 7, 2015

Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes

In by Heather DelCarpini

Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes Presentation American Diabetes Association Scientific Sessions Date June 2015 Authors Joseph Aloi,1 Robby Booth,2 Raymie McFarland,2 Jagdeesh Ullal,3 Melanie Mabrey2 Objective Hyperglycemia, regardless of its cause, is clearly associated with adverse outcomes in hospitalized patients. Hyperglycemia in patients with no known history …